Researchers identified several inflammatory circulating proteins that could be useful biomarkers for predicting outcomes in ...
Inflammation and genetic mutations can drive cardiovascular complications in patients with myeloproliferative neoplasms, which include disorders such as polycythemia vera, essential thrombocythemia, ...
In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...
Parade on MSN8d
'I Was Diagnosed With Pulmonary Arterial Hypertension At 25—This Was the First Unexpected Symptom I Experienced'Katrina Berry was 24 years old when she first started experiencing symptoms of pulmonary arterial hypertension (PAH), a ...
Jones, with Novant Health, spoke with WECT about a different type of hypertension that specifically affects the lungs’ blood ...
Increased funding and new public health policies for sickle cell research are needed to ease the burden on low-income nations ...
Although advancements have been made in treatment, many sickle cell disease warriors still face difficulties accessing ...
BACKGROUND: The European Chronic Thromboembolic Pulmonary Hypertension registry (CTEPH), conducted between 2007 and 2012, reported the major impact of pulmonary endarterectomy (PEA) on the long-term ...
Pulmonary fibrosis (PF), scarring of tissue surrounding tiny air sacs called alveoli, can result in life-threatening ...
Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Gossamer Bio (GOSS – Research Report) and keeping the price ...
Statistically significant vocal biomarker speech latency data reinforce the strong efficacy of brilaroxazine for negative symptoms and other ...
A 75-year-old woman with rheumatoid arthritis and multiple myeloma was admitted to the hospital with abdominal pain. She had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback